Effect of Fibrin Sealant on Drain Output and Duration of Hospitalization After Multilevel Anterior Cervical Fusion
- 1 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Spine
- Vol. 33 (16), E543-E547
- https://doi.org/10.1097/brs.0b013e31817c6c9b
Abstract
Retrospective matched pair analysis. To determine if fibrin sealant can decrease postoperative drain output and length of stay (LOS) after multilevel anterior cervical fusions. Despite careful hemostasis, bleeding after anterior cervical fusion can occur and may be life threatening. Although fibrin sealants are commonly used for hemostasis, no studies have been published on the efficacy of these products in achieving hemostasis after anterior cervical surgery. A retrospective age-, gender-, and fusion level-matched pair analysis was performed on 30 pairs of patients who underwent anterior cervical fusion >or= 3 levels. In the study group, after adequate hemostasis was obtained, before wound closure 2.0 mL of fibrin sealant was applied as a fine aerosolized spray over and around the plate/fusion sites and the soft tissues to seal the main operative field. A deep drain was used in all patients. Total drain output, time for the drainage to decrease to <or=20 mL per 8 hours shift, LOS, and number of readmissions were determined and analyzed by experienced and independent spine surgeons. Total drain output averaged 47 mL in the study group and 98 mL in the control group (P < 0.0001). Time for the drainage to decrease to <or=20 mL per shift averaged 17 hours (range, 8-29 hours) in the study group and 24 hours (range, 7-43 hours) in the control group (P = 0.0054). LOS averaged 1.2 days (range, 1-4 days) in the study group and 2.1 day (range, 1-5 days) in the control group (P < 0.0001). Two patients were readmitted within 4 days of discharge in each group because of swallowing difficulty, dyspnea, or pneumonia (P = 1.000). There were no adverse reactions attributable to the fibrin sealant. Application of fibrin sealant at the end of multilevel anterior cervical fusion can significantly decrease postoperative drain output and LOS.Keywords
This publication has 11 references indexed in Scilit:
- Tranexamic Acid for Hemostasis in the Surgical Treatment of Metastatic Tumors of the SpineSpine, 2006
- Nonsuture dural repair using polyglycolic acid mesh and fibrin glue: clinical application to spinal surgerySurgical Neurology, 2006
- Severe blood loss during spinal reconstructive procedures: The potential usefulness of topical hemostatic agentsMedical Hypotheses, 2005
- The use of local agents: bone wax, gelatin, collagen, oxidized celluloseEuropean Spine Journal, 2004
- An overview of blood-sparing techniques used in spine surgery during the perioperative periodEuropean Spine Journal, 2004
- Blood loss in adult spinal surgeryEuropean Spine Journal, 2004
- Tranexamic acid for major spinal surgeryEuropean Spine Journal, 2004
- Aprotinin Reduces Blood Loss During Spinal Surgery in ChildrenSpine, 2003
- A Multicenter, Prospective, Randomized Trial Evaluating a New Hemostatic Agent for Spinal SurgerySpine, 2001
- The Efficacy of Antifibrinolytics in the Reduction of Blood Loss During Complex Adult Reconstructive Spine SurgerySpine, 2001